Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The location and timing of cellular differentiation must be stringently controlled for proper organ formation. Normally, hepatocytes differentiate from hepatic progenitor cells to form the liver during development. However, previous studies have shown that the hepatic program can also be activated in non-hepatic lineage cells after exposure to particular stimuli or fusion with hepatocytes. These unexpected findings suggest that factors critical to hepatocyte differentiation exist and become activated to induce hepatocyte-specific properties in different cell types. Here, by screening the effects of twelve candidate factors, we identify three specific combinations of two transcription factors, comprising Hnf4α plus Foxa1, Foxa2 or Foxa3, that can convert mouse embryonic and adult fibroblasts into cells that closely resemble hepatocytes in vitro. The induced hepatocyte-like (iHep) cells have multiple hepatocyte-specific features and reconstitute damaged hepatic tissues after transplantation. The generation of iHep cells may provide insights into the molecular nature of hepatocyte differentiation and potential therapies for liver diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Viral screens using focused overexpression libraries can identify putative reprogramming factors, for example, by identifying a defined set of transcription factors that are selectively required to induce pluripotent stem cells (2–4,7) or trans-differentiate from mature somatic cell into another mature somatic cell (1,8–11).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [11]
In the citing paper
“Similarly, the studies in C57BL/6J and Severe combined immunodeficiency mice also have shown that after 20%-30% resection of the liver mass, significant DRs were observed at the border of the injured area, peaking on postoperative days 2-3.”
From Liver regeneration after partial hepatectomy: Triggers and mechanisms (2025) · cites this paper as [85]
In the citing paper
“Histological analysis of the liver revealed cytokeratin 19, Thy1 (CD90), A6, and epithelial cell adhesion molecule expression, indicating that these ductular structures originated from LPCs[85].”
From Liver regeneration after partial hepatectomy: Triggers and mechanisms (2025) · cites this paper as [85]
In the citing paper
“ECM remodeling is also a critical factor in the amplification of DRs. These findings indicate that ECM remodeling provides the structural framework necessary for DRs and tissue repair mechanisms.”
From Liver regeneration after partial hepatectomy: Triggers and mechanisms (2025) · cites this paper as [85]
In the citing paper
“Interestingly, these DRs were absent 24 hours after a 20%–30% resection, suggesting that LPC activation occurs later than the initiation of hepatocyte proliferation in standard PH (66%-70%) models.”
From Liver regeneration after partial hepatectomy: Triggers and mechanisms (2025) · cites this paper as [85]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,172
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,266
TM4: a free, open-source system for microarray data management and analysis
Saeed, A. I., Sharov, V., White, J., Li, J., Liang, W., Bhagabati, N., Braisted, J., Klapa, M., Currier, T., Thiagarajan, M., et al. (2003) · BioTechniques · doi:10.2144/03342mt01 · Cited by 4,837
Expression of a single transfected cDNA converts fibroblasts to myoblasts
Davis, R. L., Weintraub, H., & Lassar, A. B. (1987) · Cell · doi:10.1016/0092-8674(87)90585-x · Cited by 3,385
Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121
Direct conversion of fibroblasts to functional neurons by defined factors
Vierbuchen, T., Ostermeier, A., Pang, Z. P., Kokubu, Y., Südhof, T. C., & Wernig, M. (2010) · Nature · doi:10.1038/nature08797 · Cited by 3,017
Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors
Ieda, M., Fu, J.-D., Delgado-Olguin, P., Vedantham, V., Hayashi, Y., Bruneau, B. G., & Srivastava, D. (2010) · Cell · doi:10.1016/j.cell.2010.07.002 · Cited by 2,454
In vivo reprogramming of adult pancreatic exocrine cells to β-cells
Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J., & Melton, D. A. (2008) · Nature · doi:10.1038/nature07314 · Cited by 2,010
Microarray data normalization and transformation
Quackenbush, J. (2002) · Nature Genetics · doi:10.1038/ng1032 · Cited by 1,975
Cited by
Items 101–200 of 830
Frietze, S., Wang, R., Yao, L., Tak, Y. G., Ye, Z., Gaddis, M., Witt, H., Farnham, P. J., & Jin, V. X. (2012) · Genome Biology · doi:10.1186/gb-2012-13-9-r52 · Cited by 109
Stem cells and the evolving notion of cellular identity
Daley, G. Q. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0376 · Cited by 111
Lu, H. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.07.003 · Cited by 106
Stem Cells in Liver Diseases and Cancer: Recent Advances on the Path to New Therapies
Rountree, B. C., Mishra, L., & Willenbring, H. (2011) · Hepatology · doi:10.1002/hep.24762 · Cited by 109
Direct reprogramming of adult cells: avoiding the pluripotent state
Kelaini, S., Cochrane, A., & Margariti, A. (2014) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s38006 · Cited by 108
Reprogramming cell fates by small molecules
Ma, X., Kong, L., & Zhu, S. (2017) · Protein & Cell · doi:10.1007/s13238-016-0362-6 · Cited by 108
Haginiwa, S., & Ieda, M. (2017) · Cardiac and vascular biology · doi:10.1007/978-3-319-56106-6_6 · Cited by 98
Regulation of pluripotency and differentiation by deubiquitinating enzymes
Suresh, B., Lee, J., Kim, S., & Ramakrishna, S. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.53 · Cited by 100
Engineering Precision Medicine
Sun, W., Lee, J., Zhang, S., Benyshek, C., Dokmeci, M. R., & Khademhosseini, A. (2018) · Advanced Science · doi:10.1002/advs.201801039 · Cited by 103
CellTag Indexing: genetic barcode-based sample multiplexing for single-cell genomics
Guo, C., Kong, W., Kamimoto, K., Rivera-Gonzalez, G. C., Yang, X., Kirita, Y., & Morris, S. A. (2019) · Genome Biology · doi:10.1186/s13059-019-1699-y · Cited by 97
“Mouse embryonic fibroblasts were converted to iEPs as previously described [23, 24].”
BackgroundMethodZhang, L., Ma, X.-J.-N., Fei, Y.-Y., Han, H., Xu, J., Cheng, L., & Li, X. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108004 · Cited by 99
Direct Induction of Chondrogenic Cells from Human Dermal Fibroblast Culture by Defined Factors
Outani, H., Okada, M., Yamashita, A., Nakagawa, K., Yoshikawa, H., & Tsumaki, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077365 · Cited by 98
Molecular mechanisms controlling the phenotype and the EMT/MET dynamics of hepatocyte
Cicchini, C., Amicone, L., Alonzi, T., Marchetti, A., Mancone, C., & Tripodi, M. (2015) · Liver International · doi:10.1111/liv.12577 · Cited by 94
Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail
Moon, H., Ju, H.-L., Chung, S. I., Cho, K. J., Eun, J. W., Nam, S. W., Han, K.-H., Calvisi, D. F., & Ro, S. W. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.07.014 · Cited by 92
Deng, X., Qiu, R., Wu, Y., Li, Z., Xie, P., Zhang, J., Zhou, J., Zeng, L., Tang, J., Maharjan, A., et al. (2014) · Liver International · doi:10.1111/liv.12239 · Cited by 92
Miura, S., & Suzuki, A. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.08.020 · Cited by 91
“To this end, we referred to our previous study in which a set of two transcription factors, Hnf4a and Foxa3, was used to induce conversion of mouse fibroblasts into cells resembling hepatocytes in vitro (Sekiya and Suzuki, 2011).”
BackgroundResultInfluentialSelf-citationReprogramming of mouse fibroblasts into cardiomyocyte-like cells in vitro
Li, Q., Berry, E. C., Fu, J., Ieda, M., & Srivastava, D. (2013) · Nature Protocols · doi:10.1038/nprot.2013.067 · Cited by 99
Cellular and Molecular Basis of Liver Development
Shin, D., & Monga, S. P. S. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c120022 · Cited by 80
Swamynathan, S. K., & Wells, A. H. (2019) · The Ocular Surface · doi:10.1016/j.jtos.2019.11.005 · Cited by 92
Induced regeneration—the progress and promise of direct reprogramming for heart repair
Addis, R. C., & Epstein, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3225 · Cited by 98
Lgr5 + liver stem cells, hepatic organoids and regenerative medicine
Huch, M., Boj, S. F., & Clevers, H. (2013) · Regenerative Medicine · doi:10.2217/rme.13.39 · Cited by 88
PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness
Wang, X., Jung, Y., Jun, S., Lee, S., Wang, W., Schneider, A., Oh, Y. S., Lin, S. H., Park, B.-J., Chen, J., et al. (2016) · Nature Communications · doi:10.1038/ncomms10633 · Cited by 94
Direct Reprogramming of Human Fibroblasts to Hepatocyte-Like Cells by Synthetic Modified mRNAs
Simeonov, K. P., & Uppal, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100134 · Cited by 86
Generation of human adult hepatocyte organoids with metabolic functions
Igarashi, R., Oda, M., Okada, R., Yano, T., Takahashi, S., Pastuhov, S., Matano, M., Masuda, N., Togasaki, K., Ohta, Y., et al. (2025) · Nature · doi:10.1038/s41586-025-08861-y · Cited by 85
Restoring tumor immunogenicity with dendritic cell reprogramming
Zimmermannová, O., Ferreira, A. G., Ascic, E., Santiago, M. V., Kurochkin, I., Hansen, M., Met, Ö., Caiado, I., Shapiro, I. E., Michaux, J., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.add4817 · Cited by 104
“To recapitulate target cell identity with complete fidelity remains a challenge, mainly because of partial retention of parental identity (50).”
BackgroundProgramming and reprogramming a human heart cell
Sahara, M., Santoro, F., & Chien, K. R. (2015) · The EMBO Journal · doi:10.15252/embj.201490563 · Cited by 97
Shukla, S., Cyrta, J., Murphy, D. A., Walczak, E. G., Ran, L., Agrawal, P. K., Xie, Y., Chen, Y., Wang, S., Zhan, Y., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.10.008 · Cited by 86
Jindal, K., Adil, M. T., Yamaguchi, N., Yang, X., Wang, H. C., Kamimoto, K., Rivera-Gonzalez, G. C., & Morris, S. A. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-01931-4 · Cited by 82
“Originally reported to yield hepatocyte-like cells 31 , we have previously shown that Hnf4α and Foxa1 OE in MEFs generates cells with the broader potential to functionally engraft liver and intestine 17,32,35 .”
CellOracle: Dissecting cell identity via network inference and in silico gene perturbation
Kamimoto, K., Hoffmann, C. M., & Morris, S. A. (2020) · doi:10.1101/2020.02.17.947416 · Cited by 81
Small Molecules Facilitate Single Factor-Mediated Hepatic Reprogramming
Lim, K. T., Lee, S. C., Gao, Y., Kim, K.-P., Song, G., An, S. Y., Adachi, K., Jang, Y. J., Kim, J., Oh, K.-J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.071 · Cited by 81
Lee, S. Y., Kim, H., & Choi, D. (2015) · International Journal of Stem Cells · doi:10.15283/ijsc.2015.8.1.36 · Cited by 86
Morris, S. A. (2016) · Development · doi:10.1242/dev.138263 · Cited by 79
Steinle, H., Behring, A., Schlensak, C., Wendel, H. P., & Avci-Adali, M. (2017) · Stem Cells · doi:10.1002/stem.2402 · Cited by 76
Zhang, C., Xie, B., Zou, Y., Zhu, D., Lei, L., Zhao, D., & Nie, H. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.06.020 · Cited by 80
Identification of Transcription Factors for Lineage-Specific ESC Differentiation
Yamamizu, K., Piao, Y., Sharov, A. A., Zsiros, V., Yu, H., Nakazawa, K., Schlessinger, D., & Ko, M. S. H. (2013) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.10.006 · Cited by 94
Magner, N. L., Jung, Y., Wu, J., Nolta, J. A., Zern, M. Α., & Zhou, P. (2013) · Stem Cells · doi:10.1002/stem.1478 · Cited by 95
Thakur, A., Wong, J. C. H., Wang, E. Y., Lotto, J., Kim, D., Cheng, J., Mingay, M., Cullum, R., Moudgil, V., Ahmed, N., et al. (2019) · Hepatology · doi:10.1002/hep.30631 · Cited by 68
“These studies revealed that HNF4A is crucial for generating induced hepatocyte-like cells (iHeps),(25,26) given that HNF4A overexpression alone may be sufficient to generate these cells.”
BackgroundThe lncRNA HOTAIR transcription is controlled by HNF4α-induced chromatin topology modulation
Battistelli, C., Sabarese, G., Santangelo, L., Montaldo, C., Gonzalez, F. J., Tripodi, M., & Cicchini, C. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0170-z · Cited by 79
Conversion of hepatoma cells to hepatocyte-like cells by defined hepatocyte nuclear factors
Cheng, Z., He, Z., Cai, Y., Zhang, C., Fu, G., Li, H., Sun, W. C., Liu, C., Cui, X., Ning, B., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0111-x · Cited by 88
Direct conversion of mouse fibroblasts into induced neural stem cells
Kim, S. M., Flaßkamp, H., Hermann, A., Araúzo-Bravo, M. J., Lee, S. C., Lee, S. H., Seo, E. H., Lee, S., Storch, A., Lee, H. T., et al. (2014) · Nature Protocols · doi:10.1038/nprot.2014.056 · Cited by 79
Transdifferentiation: a new promise for neurodegenerative diseases
Mollinari, C., Zhao, J., Lupacchini, L., Garaci, E., Merlo, D., & Pei, G. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0891-4 · Cited by 83
GATA family members as inducers for cellular reprogramming to pluripotency
Shu, J., Zhang, K., Zhang, M., Yao, A., Shao, S., Du, F., Yang, C., Chen, W., Wu, C., Yang, W., et al. (2015) · Cell Research · doi:10.1038/cr.2015.6 · Cited by 75
Direct conversion of human fibroblasts into retinal pigment epithelium-like cells by defined factors
Zhang, K., Liu, G., Yi, F., Montserrat, N., Hishida, T., Esteban, C. R., & Belmonte, J. C. I. (2013) · Protein & Cell · doi:10.1007/s13238-013-0011-2 · Cited by 78
Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction
Segovia-Zafra, A., Di Zeo-Sánchez, D. E., López-Gómez, C., Pérez-Valdés, Z., García-Fuentes, E., Andrade, R. J., Lucena, M. I., & Villanueva-Paz, M. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.11.013 · Cited by 70
Direct conversion of mouse and human fibroblasts to functional melanocytes by defined factors
Yang, R., Zheng, Y., Li, L., Liu, S., Burrows, M., Wei, Z., Nace, A., Herlyn, M., Cui, R., Guo, W., et al. (2014) · Nature Communications · doi:10.1038/ncomms6807 · Cited by 84
Kim, Y., Hong, S.-A., Yu, J., Eom, J., Jang, K., Yoon, S., Hong, D. H., Seo, D., Lee, S.-N., Woo, J.-S., et al. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.04.010 · Cited by 69
Three-Dimensional Bioprinting of Hepatic Structures with Directly Converted Hepatocyte-Like Cells
Kang, K., Kim, Y., Jeon, H., Lee, S. B., Kim, J. S., Park, S. A., Kim, W. D., Yang, H. M., Kim, S. J., Jeong, J., et al. (2018) · Tissue Engineering Part A · doi:10.1089/ten.tea.2017.0161 · Cited by 71
Liver cell therapy: is this the end of the beginning?
Alwahsh, S. M., Rashidi, H., & Hay, D. C. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2713-8 · Cited by 71
Kishida, T., Ejima, A., Yamamoto, K., Tanaka, S., Yamamoto, T., & Mazda, O. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.08.007 · Cited by 67
The Dynamics of Transcriptional Activation by Hepatic Reprogramming Factors
Horisawa, K., Udono, M., Ueno, K., Ohkawa, Y., Nagasaki, M., Sekiya, S., & Suzuki, A. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.07.012 · Cited by 68
Self-citationPathophysiology and therapeutic potential of cardiac fibrosis
Hara, H., Takeda, N., & Komuro, I. (2017) · Inflammation and Regeneration · doi:10.1186/s41232-017-0046-5 · Cited by 76
Quaking Is a Key Regulator of Endothelial Cell Differentiation, Neovascularization, and Angiogenesis
Cochrane, A., Kelaini, S., Tsifaki, M., Bojdo, J., González, M. V., Drehmer, D., Caines, R., Magee, C., Eleftheriadou, M., Hu, Y., et al. (2017) · Stem Cells · doi:10.1002/stem.2594 · Cited by 74
Epigenetic control of EMT/MET dynamics: HNF4α impacts DNMT3s through miRs-29
Cicchini, C., de Nonno, V., Battistelli, C., Cozzolino, A. M., De Santis Puzzonia, M., Ciafrè, S. A., Brocker, C., Gonzalez, F. J., Amicone, L., & Tripodi, M. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.05.005 · Cited by 66
Human Pluripotent Stem Cell-Derived Cardiomyocytes as Research and Therapeutic Tools
Acimovic, I., Vilotic, A., Pesl, M., Lacampagne, A., Dvorak, P., Rotrekl, V., & Meli, A. C. (2014) · BioMed Research International · doi:10.1155/2014/512831 · Cited by 66
Qu, M., Qu, H., Jia, Z., & Kay, S. A. (2021) · Nature Communications · doi:10.1038/s41467-021-26567-3 · Cited by 65
Cellular Reprogramming of Human Peripheral Blood Cells
Zhang, X. (2013) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2013.09.001 · Cited by 71
RNA-Based Tools for Nuclear Reprogramming and Lineage-Conversion: Towards Clinical Applications
Bernal, J. A. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9494-8 · Cited by 65
Pluripotent stem cell-based disease modeling: current hurdles and future promise
Zeltner, N., & Studer, L. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.10.008 · Cited by 71
Human Induced Pluripotent Stem Cells in Hepatology
Gerbal-Chaloin, S., Funakoshi, N., Caillaud, A., Gondeau, C., Champon, B., & Si-Tayeb, K. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.09.026 · Cited by 64
Concise Review: Dedifferentiation Meets Cancer Development: Proof of Concept for Epigenetic Cancer
Yamada, Y., Haga, H., & Yamada, Y. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0090 · Cited by 78
De novo assembly of plant body plan: a step ahead of Deadpool
Kareem, A., Radhakrishnan, D., Sondhi, Y., Aiyaz, M., Roy, M. V., Sugimoto, K., & Prasad, K. (2016) · Regeneration · doi:10.1002/reg2.68 · Cited by 66
“…in animal systems wherein a differentiated cell can be directly converted into a different lineage without passing through an intermediate pluripotent state by the forced expression of tissue-specific transcription factors (Ieda et al., 2010; Vierbuchen et al., 2010; Sekiya & Suzuki, 2011).”
BackgroundNakamori, D., Akamine, H., Takayama, K., Sakurai, F., & Mizuguchi, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-16856-7 · Cited by 64
FOXF1 Defines the Core-Regulatory Circuitry in Gastrointestinal Stromal Tumor
Ran, L., Chen, Y., Sher, J. J., Wong, E. W. P., Murphy, D. A., Zhang, J. Q., Li, D., Denız, K., Sirota, I., Cao, Z., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0468 · Cited by 71
The ETS Factor, ETV2: a Master Regulator for Vascular Endothelial Cell Development
Oh, S.-Y., Kim, J. Y., & Park, C. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.0331 · Cited by 74
Regulation of hepatocyte identity and quiescence
Berasain, C., & Avila, M. A. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1970-7 · Cited by 68
“These strategies produced functional hepatocyte-like cells through the expression of defined transcription factors such as HNF1a, HNF4a, FOXA1, FOXA2 and GATA4 [222, 223], or through the generation of multipotent progenitor cells that were subsequently differentiated into hepatocytic cells upon stimulation with factor…”
BackgroundCapybara: A computational tool to measure cell identity and fate transitions
Kong, W., Fu, Y. C., Holloway, E. M., Garipler, G., Yang, X., Mazzoni, E. O., & Morris, S. A. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.03.001 · Cited by 64
“The overexpression of TFs Foxa1 and Hnf4a in mouse embryonic fibroblasts (MEFs) was initially designed to yield hepatocyte-like cells (Sekiya and Suzuki, 2011).”
BackgroundThe Pharmacology of Regenerative Medicine
Christ, G. J., Saul, J. M., Furth, M. E., & Andersson, K. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007393 · Cited by 65
Cell Reprogramming: The Many Roads to Success
Aydin, B., & Mazzoni, E. O. (2019) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100818-125127 · Cited by 62
Human Pluripotent Stem Cells for Modelling Human Liver Diseases and Cell Therapy
Dianat, N., Steichen, C., Vallier, L., Weber, A., & Dubart-Kupperschmitt, A. (2013) · Current Gene Therapy · doi:10.2174/1566523211313020006 · Cited by 59
Engineering Biomaterials with Micro/Nanotechnologies for Cell Reprogramming
Fang, J., Hsueh, Y., Soto, J., Sun, W., Wang, J., Gu, Z., Khademhosseini, A., & Li, S. (2020) · ACS Nano · doi:10.1021/acsnano.9b04837 · Cited by 63
Nonviral Direct Conversion of Primary Mouse Embryonic Fibroblasts to Neuronal Cells
Adler, A. F., Grigsby, C. L., Kulangara, K., Wang, H., Yasuda, R., & Leong, K. W. (2012) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2012.25 · Cited by 62
Molecular mechanisms underlying the enhanced functions of three-dimensional hepatocyte aggregates
Chang, T. T., & Hughes-Fulford, M. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.063 · Cited by 59
“Moreover, ectopic expression of Hnf4a is required for conversion of fibroblasts to hepatocyte-like cells that havemature hepatocyte functions, including the ability to reconstitute liver tissue after transplantation [52].”
BackgroundA test of the pioneer factor hypothesis using ectopic liver gene activation
Hansen, J. L., Loell, K., & Cohen, B. A. (2022) · eLife · doi:10.7554/elife.73358 · Cited by 68
Embryonic Stem Cells Induce Pluripotency in Somatic Cell Fusion through Biphasic Reprogramming
Foshay, K. M., Looney, T. J., Chari, S., Mao, F. F., Lee, J. H., Zhang, L., Fernandes, C. J., Baker, S. W., Clift, K. L., Gaetz, J., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.02.013 · Cited by 65
Making a Hematopoietic Stem Cell
Daniel, M. G., Pereira, C., Lemischka, I. R., & Moore, K. A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.10.002 · Cited by 69
Chemical compound-based direct reprogramming for future clinical applications.
Takeda, Y., Harada, Y., Yoshikawa, T., & Dai, P. (2018) · Bioscience Reports · doi:10.1042/bsr20171650 · Cited by 57
Defining the Minimal Factors Required for Erythropoiesis through Direct Lineage Conversion
Capellera-Garcia, S., Pulecio, J., Dhulipala, K., Siva, K., Rayon-Estrada, V., Singbrant, S., Sommarin, M. N. E., Walkley, C. R., Soneji, S., Karlsson, G., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.027 · Cited by 56
“This approach, called direct lineage reprogramming, can yield a wide range of clinically relevant cell types, such as neurons, cardiomyocytes, and hepatocytes (Huang et al., 2011; Ieda et al., 2010; Sekiya and Suzuki, 2011; Vierbuchen et al., 2010).”
BackgroundChemical Modulation of Cell Fate in Stem Cell Therapeutics and Regenerative Medicine
Liu, K., Chen, Y., Xie, M., Li, K., & Ding, S. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.07.007 · Cited by 67
Cell Fate Reprogramming in the Era of Cancer Immunotherapy
Zimmermannova, O., Caiado, I., Ferreira, A. G., & Pereira, C.-F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.714822 · Cited by 56
Direct Cardiac Reprogramming: From Developmental Biology to Cardiac Regeneration
Li, Q., & Srivastava, D. (2013) · Circulation Research · doi:10.1161/circresaha.112.300625 · Cited by 64
Cui, L., Shi, Y., Zhou, X., Wang, X., Wang, J., Lan, Y., Wang, M., Zheng, L. T., Li, H., Wu, Q., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.429 · Cited by 56
Tanimizu, N., Nakamura, Y., Ichinohe, N., Mizuguchi, T., Hirata, K., & Mitaka, T. (2013) · Journal of Cell Science · doi:10.1242/jcs.133082 · Cited by 64
“Our results suggest that it is not easy to convert the mass of mature cholangiocytes to hepatocytes; however, several groups have reported that hepatocytes can be produced from pluripotent stem cells or somatic cells (Si-Tayeb et al., 2010; Huang et al., 2011; Sekiya and Suzuki, 2011).”
BackgroundProgress in human liver organoids
Sun, L., & Hui, L. (2020) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaa013 · Cited by 54
“Forced activation of liver transcriptional factors converts fibroblasts into hepatocyte-like cells directly, a process also named as transdifferentiation (Huang et al., 2011, 2014; Sekiya and Suzuki, 2011; Du et al., 2014).”
BackgroundKosaka, T., Nagamatsu, G., Saito, S., Oya, M., Suda, T., & Horimoto, K. (2013) · Cancer Science · doi:10.1111/cas.12183 · Cited by 53
Vanzan, L., Soldati, H., Ythier, V., Anand, S., Braun, S. M. G., Francis, N., & Murr, R. (2021) · Nature Communications · doi:10.1038/s41467-021-23630-x · Cited by 52
Zhu, S., Wang, H., & Ding, S. (2015) · Nature Protocols · doi:10.1038/nprot.2015.059 · Cited by 55
McDaniel, K., Meng, F., Wu, N., Sato, K., Venter, J., Bernuzzi, F., Invernizzi, P., Zhou, T., Kyritsi, K., Wan, Y., et al. (2017) · Hepatology · doi:10.1002/hep.28831 · Cited by 52
Tsuchiya, H., da Costa, K.-A., Lee, S., Renga, B., Jaeschke, H., Yang, Z., Orena, S., Goedken, M. J., Zhang, Y., Kong, B., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.01.045 · Cited by 51
“Disruptions of Met homeostasis that result in hyperhomocysteinemia (HHcy) increase risk for cardiovascular and cerebrovascular diseases and metabolic disorders.(4,5) The small heterodimer partner (SHP, NR0B2) serves as an important regulator of lipid and bile acid metabolism, and of circadian rhythms in the liver.”
BackgroundEnhancer reprogramming: critical roles in cancer and promising therapeutic strategies
Yang, J., Zhou, F., Luo, X., Fang, Y., Wang, X., Liu, X., Xiao, R., Jiang, D., Tang, Y., Yang, G., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02366-3 · Cited by 63
Kim, J. B., Lee, H.-A., Araúzo-Bravo, M. J., Hwang, K., Nam, D., Park, M. R., Zaehres, H., Park, K. I., & Lee, S. (2015) · The EMBO Journal · doi:10.15252/embj.201592652 · Cited by 54
“…cardiomyocytes, and endothelial cells, has been developed, which eliminates tumorigenicity through bypassing an intermediate pluripotent state (Davis et al , 1987; Efe et al , 2011; Huang et al , 2011, 2014; Sekiya & Suzuki, 2011; Li et al , 2013; Han et al , 2014; Morita et al , 2015).”
Steward, M., Sridhar, A., & Meyer, J. S. (2012) · Current topics in microbiology and immunology · doi:10.1007/82_2012_302 · Cited by 66
Human liver model systems in a dish
Thompson, W. L., & Takebe, T. (2021) · Development Growth & Differentiation · doi:10.1111/dgd.12708 · Cited by 60
“Of note is the method of direct reprogramming of fibroblasts into hepatocyte- like cells that are functionally active (Du et al., 2014; Huang et al., 2014; Sekiya & Suzuki, 2011; Xie et al., 2019).”
MethodPotential of human induced pluripotent stem cells in studies of liver disease
Sampaziotis, F., Segeritz, C., & Vallier, L. (2015) · Hepatology · doi:10.1002/hep.27651 · Cited by 49
Bi, Y., He, Y., Huang, J., Su, Y., Zhu, G., Wáng, Y., Qiao, M., Zhang, B., Zhang, H., Wang, Z., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000366340 · Cited by 50
Pluripotent Stem Cell–Derived Hepatocytes: Potential and Challenges in Pharmacology
Szkolnicka, D., Zhou, W., Lucendo-Villarin, B., & Hay, D. C. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140306 · Cited by 48
Cellular reprogramming – lowering gravity on Waddington's epigenetic landscape
Takahashi, K. (2012) · Journal of Cell Science · doi:10.1242/jcs.084822 · Cited by 61
“Another study investigated 12 candidate genes, which are all relevant to hepatic development, as reprogramming factors (Sekiya and Suzuki, 2011).”
BackgroundKanki, Y., Nakaki, R., Shimamura, T., Matsunaga, T., Yamamizu, K., Katayama, S., Suehiro, J.-I., Osawa, T., Aburatani, H., Kodama, T., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx159 · Cited by 50
Maucksch, C., Jones, K. S., & Connor, B. J. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0179 · Cited by 51
Nakamori, D., Takayama, K., Nagamoto, Y., Mitani, S., Sakurai, F., Tachibana, M., & Mizuguchi, H. (2016) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2015.12.007 · Cited by 43
GATA4 loss of function in liver cancer impedes precursor to hepatocyte transition
Enane, F. O., Shuen, T. W. H., Gu, X., Ebrahem, Q., Przychodzen, B. P., Makishima, H., Bodo, J., Ng, J., Chee, C. L., Ba, R., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93488 · Cited by 54
Metadata
- Authors
- Sekiya, S., & Suzuki, A.
- Affiliations
- Kyushu University (JP)
- Corresponding author
- Suzuki, Atsushi
- ORCID
- Suzuki, Atsushi
- Venue
- Nature
- Published
- 2011-06-29
- Volume
- 475
- Issue
- 7356
- Pages
- 390-393
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2008365696
- Cited by
- 846
- References
- 31
- Citations by year
- 2026: 19 · 2025: 30 · 2024: 18 · 2023: 36 · 2022: 50 · 2021: 42 · 2020: 44 · 2019: 46 · 2018: 60 · 2017: 68 · 2016: 88 · 2015: 68 · 2014: 82 · 2013: 102 · 2012: 69
- FWCI
- 35.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Kyushu University Institutional Repository (QIR) (Kyushu University) (submittedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Funders
- Japan Society for the Promotion of Science (23112002, 22390054)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- direct conversion, hepatocyte differentiation, transcription factors, HNF4α, FOXA1, FOXA2, FOXA3, GATA4, HNF1A, p19ARF, liver regeneration, liver injury, cell transplantation, regenerative medicine
- MeSH terms
- Animals, Cell Differentiation, Cells, Cultured, Embryo, Mammalian, Fibroblasts, Hydrolases, Liver, Mice, Inbred BALB C, Mice, Inbred C57BL, Hepatocytes, Mice, Hepatocyte Nuclear Factor 3-alpha, Hepatocyte Nuclear Factor 3-beta, Hepatocyte Nuclear Factor 3-gamma, Hepatocyte Nuclear Factor 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.